Complete Blood Count Device Market

Global Complete Blood Count Device Market Is Estimated To Witness High Growth Owing To Increased Prevalence of Blood Disorders

by

The global Complete Blood Count Device Market is estimated to be valued at US$ 3,642.9 million in 2021 and is expected to exhibit a CAGR of 8.3% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The Complete Blood Count Device Market is witnessing significant growth due to various factors such as the increasing prevalence of chronic diseases, rising demand for early and accurate diagnosis, and technological advancements in laboratory diagnostics. However, the market also faces challenges such as the high cost of advanced blood count devices and the lack of skilled professionals.

Market key trends:
One of the key trends in the Complete Blood Count Device Market is the increasing adoption of point-of-care testing. Point-of-care testing allows healthcare professionals to obtain rapid results, enabling immediate decision-making and treatment. For example, Sight Diagnostics has developed an innovative blood count device called the OLO analyzer, which provides lab-grade results within minutes at the point of care. This trend is driven by the need for faster diagnosis and personalized treatment options.

Segment Analysis:
The Complete Blood Count Device Market is segmented based on technology and end-users. Among the technology segment, the automated hematology analyzers segment dominates the market and is expected to continue its dominance over the forecast period. This is due to the advantages offered by these analyzers, such as high throughput, accurate results, and ease of use. The increasing adoption of automated hematology analyzers in clinical laboratories and hospitals contributes to its dominance in the market.

Key Takeaways:
The global Complete Blood Count Device Market Growth is expected to witness high growth, exhibiting a CAGR of 8.3% over the forecast period, due to increasing demand for early and accurate diagnosis.
The Asia Pacific region is the fastest-growing and dominating region in the market, driven by the rising prevalence of chronic diseases and improving healthcare infrastructure.
Key players operating in the global Complete Blood Count Device Market include Abbott Laboratories, bioMérieux SA, Danaher Corporation, Siemens Healthineers, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Sysmex Asia Pacific Pte Ltd, Becton, Dickinson and Company, Sight Diagnostics, Horiba, and Nihon Kohden Corporation.

The global Complete Blood Count Device Market is experiencing significant growth due to the increasing demand for early and accurate diagnosis. The market is dominated by automated hematology analyzers segment and the Asia Pacific region is the fastest-growing region. Key players in the market are continuously focusing on research and development activities to introduce innovative solutions for blood count testing.